Total Payments
$6,269
2024 Payments
$1,275
Companies
44
Transactions
403
Medicare Patients
2,053
Medicare Billing
$196,962
Payment Breakdown by Category
Food & Beverage$6,269 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,269 | 403 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $764.28 | 53 | $0 (2024) |
| ABBVIE INC. | $704.89 | 53 | $0 (2024) |
| Lilly USA, LLC | $628.50 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $410.07 | 21 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $401.89 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $398.63 | 23 | $0 (2024) |
| PFIZER INC. | $304.88 | 15 | $0 (2024) |
| Abbott Laboratories | $272.65 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $244.88 | 19 | $0 (2024) |
| Amgen Inc. | $244.77 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,275 | 72 | Lilly USA, LLC ($262.07) |
| 2023 | $1,253 | 76 | Lilly USA, LLC ($205.20) |
| 2022 | $632.49 | 47 | ABBVIE INC. ($174.92) |
| 2021 | $1,076 | 79 | AbbVie Inc. ($356.97) |
| 2020 | $709.05 | 57 | Allergan, Inc. ($150.71) |
| 2019 | $834.44 | 51 | Novo Nordisk Inc ($225.17) |
| 2018 | $216.21 | 12 | Janssen Pharmaceuticals, Inc ($87.34) |
| 2017 | $272.19 | 9 | PFIZER INC. ($116.43) |
All Payment Transactions
403 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.49 | General |
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Bone Health | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Cardio-renal | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.06 | General |
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.10 | General |
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 521 | 741 | $140,194 | $49,933 |
| 2022 | 9 | 500 | 702 | $132,334 | $46,642 |
| 2021 | 9 | 552 | 772 | $150,928 | $56,224 |
| 2020 | 7 | 480 | 724 | $123,194 | $44,163 |
Total Patients
2,053
Total Services
2,939
Medicare Billing
$196,962
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 308 | $74,844 | $22,231 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $29,512 | $14,210 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 152 | $26,144 | $8,059 | 30.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 38 | 38 | $5,054 | $2,881 | 57.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,890 | $1,201 | 63.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 28 | 35 | $2,170 | $1,082 | 49.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 23 | $460.00 | $218.96 | 47.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 19 | 24 | $120.00 | $50.87 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 153 | 281 | $68,220 | $19,756 | 29.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 123 | 123 | $30,490 | $15,030 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 104 | 160 | $27,515 | $8,834 | 32.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 17 | 17 | $2,261 | $1,194 | 52.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 27 | 31 | $2,177 | $947.36 | 43.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 21 | $945.00 | $539.90 | 57.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 23 | $460.00 | $220.92 | 48.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 24 | 28 | $140.00 | $62.25 | 44.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 13 | 18 | $126.00 | $58.48 | 46.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 179 | 357 | $86,505 | $27,956 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 124 | 124 | $30,780 | $15,465 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 92 | 124 | $21,142 | $6,684 | 31.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 47 | 47 | $5,724 | $3,063 | 53.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 13 | 13 | $4,134 | $2,067 | 50.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 44 | 44 | $1,980 | $687.28 | 34.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 19 | $380.00 | $184.49 | 48.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 17 | 19 | $133.00 | $62.32 | 46.9% |
About Dr. Peter Ko, MD
Dr. Peter Ko, MD is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730145012.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Ko, MD has received a total of $6,269 in payments from pharmaceutical and medical device companies, with $1,275 received in 2024. These payments were reported across 403 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,269).
As a Medicare-enrolled provider, Ko has provided services to 2,053 Medicare beneficiaries, totaling 2,939 services with total Medicare billing of $196,962. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 04/25/2006
- Last Updated 05/08/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1730145012
Products in Payments
- UBRELVY (Drug) $384.90
- JARDIANCE (Drug) $377.84
- VRAYLAR (Drug) $326.37
- MOUNJARO (Drug) $293.41
- FARXIGA (Drug) $275.01
- NURTEC ODT (Drug) $271.16
- Ozempic (Drug) $221.86
- ELIQUIS (Drug) $216.48
- Tresiba (Drug) $202.51
- GVOKE HYPOPEN (Drug) $195.26
- TRELEGY ELLIPTA (Drug) $186.11
- JANUVIA (Drug) $168.40
- FREESTYLE LIBRE 2 (Device) $155.31
- AIMOVIG (Biological) $149.09
- LEQVIO (Drug) $143.06
- XARELTO (Drug) $136.40
- TRULICITY (Drug) $110.18
- ENTRESTO (Drug) $106.48
- EVENITY (Biological) $104.94
- BREZTRI (Drug) $96.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
John Richard, Md, MD
Family Medicine — Payments: $438,915
Family Medicine $438,915
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475